Appendix 2. Reviewer Disclosures

Reviewer Disclosures
Reviewer Employment Research Grant Other Research Support Speakers' Bureau/
Honoraria
Expert Witness Ownership Interest Consultant/
Advisory Board
Other
Clifton Callaway University of Pittsburgh NIH (Grants to study emergency care, including treatment of cardiac arrest and cardiac emergencies)† None None None None None None
Alix Carter Dalhousie University (Canada) Maritime Heart (descriptive factors survival ohca)* None None None None None None
Henry Halperin Johns Hopkins University Zoll Circulation (CPR research)†; NIH (CPR research)† None None None None None None
Timothy Henry The Christ Hospital None None None None None None None
Jonathan Jui Oregon Health and Science University NIH (HL 126938)* None None None None None None
Tommaso Pellis AAS 5 Friuli Occidentale (Italy) None None None None None None None
Fred Severyn Denver Health and Hospital Authority; University of Colorado Anschutz Medical Campus; University of Arkansas for Medical Sciences None None None None None None None
Andrew H. Travers Emergency Health Services, Nova Scotia (Canada) None None None None None None None

This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*Modest.
†Significant